SEARCH

SEARCH BY CITATION

References

  • 1
    Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. 1976;18:255264.
  • 2
    Benomar B, Ouattara A, Estagnasie P, et al. Fluid responsiveness predicted by noninvasive bioreactance-based passive leg raise test. Intensive Care Med. 2010;36:18751881.
  • 3
    Caille V, Jabot J, Belliard G, et al. Hemodynamic effects of passive leg raising: an echocardiographic study in patients with shock. Intensive Care Med. 2008;34:12391245. Epub 2008 Mar 1220.
  • 4
    Jabot J, Teboul J, Richard C, Monnet X. Passive leg raising for predicting fluid responsiveness: importance of the postural change. Intensive Care Med. 2009;35:8590. Epub 2008 Sep 2016.
  • 5
    Lafanechere A, Pene F, Goulenok C, et al. Changes in aortic blood flow induced by passive leg raising predict fluid responsiveness in critically ill patients. Crit Care. 2006;10:R132.
  • 6
    Lakhal K, Ehrmann S, Runge I, et al. Central venous pressure measurements improve the accuracy of leg raising-induced change in pulse pressure to predict fluid responsiveness. Intensive Med. 2010;36:940948.
  • 7
    Monnet X, Rienzo M, Osman D, et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006;34:14021407.
  • 8
    Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825832.
  • 9
    Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an “emergency” cardiac hormone against ventricular overload. J Clin Invest. 1995;96:12801287.
  • 10
    Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996;93:19631969.
  • 11
    Luchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol. 1998;274:H1684H1689.
  • 12
    Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161167.
  • 13
    Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635641.
  • 14
    Mueller C, Laule-Kilian K, Scholer A, et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am J Cardiol. 2004;94:15101514.
  • 15
    Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386391.
  • 16
    Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:11261130.
  • 17
    Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 2007;116:249257.
  • 18
    Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol. 2007;49:17331739.
  • 19
    Vanderheyden M, Goethals M, Verstreken S, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol. 2004;44:23492354.
  • 20
    Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007;293:H583H589.
  • 21
    Squara P. Bioreactance, a new method for non invasive cardiac output monitoring. In: Vincent J, ed. Year Book of Intensive Care and Emergency Medicine. Paris: Springer; 2008:619630.
  • 22
    Squara P, Denjean D, Estagnasie P, et al. Noninvasive cardiac output monitoring (NICOM): a clinical validation. Intensive Care Med. 2007;33:11911194.
  • 23
    Marqué S, Cariou A, Chiche J, Squara P. Non invasive cardiac output monitoring (NICOM) compared to minimally invasive monitoring (VIGILEO). Crit Care. 2009;13:R73.
  • 24
    Squara P, Rotcajg D, Denjean D, et al. Comparison of monitoring performance of Bioreactance vs pulse contour during lung recruitment maneuvers. Crit Care. 2009;13:R125.
  • 25
    Wang J, Wu M, Mao T, et al. Effects of normoxic and hypoxic exercise regimens on cardiac, muscular, and cerebral hemodynamics suppressed by severe hypoxia in humans. J Appl Physiol. 2010;109:219229.
  • 26
    Rosenblum H, Helmke S, Williams P, et al. Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure. Congest Heart Fail. 2010;16:254258.
  • 27
    Maurer MM, Burkhoff D, Maybaum S, et al. A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. J Card Fail. 2009;15:689699.
  • 28
    Kossari N, Hufnagel G, Squara P. Bioreactance: a new tool for cardiac output and thoracic fluid content monitoring during hemodialysis. Hemodial int. 2009;13:512517.
  • 29
    Lewin J, Ledwidge M, O'Loughlin C, et al. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis. Eur J Heart Failure. 2005;7:953957.
  • 30
    Amoore JN, Geake WB. Evaluation of the Critikon 8100 and Spacelabs 90207 non-invasive blood pressure monitors using a test simulator. J Hum Hypertens. 1997;11:163169.
  • 31
    Squara P, Cecconi M, Rhodes A, et al. Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Med. 2009;35:18011808.
  • 32
    Greene A, Shoukas A. Changes in canine cardiac function and venous return curves by the carotid baroreflex. Am J Physiol. 1986;25:12881296.
  • 33
    Takata M, Wise R, Robotham J. Effects of abdominal pressure on venous return: abdominal vascular zone conditions. J Appl Physiol. 1990;69:19611972.
  • 34
    Kitano Y, Takata M, Sasaki N, et al. Influence of increased abdominal pressure on steady-state cardiac performance. J Appl Physiol. 1999;86:16511656.
  • 35
    Fessler H, Brower R, Shapiro E, Permutt S. Effects of positive end-expiratory pressure and body position on pressure in the thoracic great veins. Am Rev Respir Dis. 1993;148:16571664.
  • 36
    Mekontso-Dessap A, Tual L, Kirsch M, et al. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br J Anaesth. 2006;97:777782.
  • 37
    Muller L, Louart G, Teboul JL, et al. Could B-type natriuretic peptide (BNP) plasma concentration be useful to predict fluid responsiveness [corrected] in critically ill patients with acute circulatory failure? Ann Fr Anesth Reanim. 2009;28:531536.
  • 38
    Sturgess DJ, Pascoe RL, Scalia G, Venkatesh B. A comparison of transcutaneous Doppler corrected flow time, B-type natriuretic peptide and central venous pressure as predictors of fluid responsiveness in septic shock: a preliminary evaluation. Anaesth Intensive Care. 2010;38:336341.
  • 39
    Pirracchio R, Deye N, Lukaszewicz AC, et al. Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med. 2008;36:25422546.
  • 40
    Lang CC, Karlin P, Haythe J, et al. Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009;2:3338.
  • 41
    Williams SG, Tzeng BH, Barker D, Tan LB. Comparison and relation of indirect and direct dynamic indexes of cardiac pumping capacity in chronic heart failure. Am J Cardiol. 2005;96:11491150.
  • 42
    Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423433.